ASP Isotopes Issues Business Update, Expects First Commercial Shipments In 2026

Benzinga Newsdesk www.benzinga.com Positive 68.0%

Neg 0% Neu 0% Pos 68%

Expect to Obtain Helium Phase 1 Nameplate Capacity in Q3 2026
EBITDA Target of Greater Than $300 Million in 2031
Cash, Cash Equivalents and Short-Term Marketable Securities of $333 million as of December 31, 2025

Comments

No comments yet. Be the first!